Form 8-K - Current report:
SEC Accession No. 0001214659-23-009927
Filing Date
2023-07-25
Accepted
2023-07-24 21:25:22
Documents
13
Period of Report
2023-07-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 j7242308k.htm   iXBRL 8-K 30603
  Complete submission text file 0001214659-23-009927.txt   230632

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hgen-20230718.xsd EX-101.SCH 2991
3 XBRL DEFINITION FILE hgen-20230718_def.xml EX-101.DEF 26174
4 XBRL LABEL FILE hgen-20230718_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE hgen-20230718_pre.xml EX-101.PRE 22343
7 EXTRACTED XBRL INSTANCE DOCUMENT j7242308k_htm.xml XML 3283
Mailing Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078
Business Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078 (973) 200-3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 231106279
SIC: 2834 Pharmaceutical Preparations